Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
270.28
224.26
183.01
138.83
117.06
131.31
80.26
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
270.28
224.26
183.01
138.83
117.06
131.31
80.26
Raw Material Cost
116.31
92.54
71.62
55.16
44.50
52.01
24.92
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
9.13
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.18
0.78
0.42
0.20
0.32
0.51
0.31
Selling and Distribution Expenses
129.37
112.13
93.19
73.36
60.04
57.71
45.27
Other Expenses
-0.73
0.23
0.24
0.25
0.18
0.06
0.05
Total Expenditure (Excl Depreciation)
248.70
207.74
167.59
131.22
106.66
110.81
71.04
Operating Profit (PBDIT) excl Other Income
21.6
16.5
15.4
7.6
10.4
20.5
9.200000000000001
Other Income
2.24
0.95
-0.65
-0.35
-0.45
2.33
-0.36
Operating Profit (PBDIT)
52.69
41.30
36.76
23.88
22.89
32.86
15.15
Interest
1.18
0.78
0.42
0.20
0.32
0.51
0.31
Exceptional Items
-1.12
-0.35
-0.05
0.94
1.24
3.59
0.36
Gross Profit (PBDT)
153.97
131.72
111.39
83.67
72.56
79.30
55.34
Depreciation
28.61
24.00
21.89
15.63
11.31
9.58
6.40
Profit Before Tax
21.77
16.17
14.39
8.99
12.50
26.36
8.80
Tax
6.39
4.76
4.15
2.77
3.38
-5.17
0.27
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
14.93
11.27
10.24
6.22
9.13
31.53
8.53
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
14.93
11.27
10.24
6.22
9.13
31.53
8.53
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.44
0.14
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
15.38
11.41
10.24
6.22
9.13
31.53
8.53
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
141.54
131.39
113.89
97.09
94.82
81.69
43.70
Earnings per share (EPS)
0.37
0.28
0.25
0.16
0.22
0.78
0.21
Diluted Earnings per share
0.37
0.28
0.25
0.16
0.22
0.78
0.21
Operating Profit Margin (Excl OI)
8.08%
7.29%
8.48%
6.19%
10.27%
15.96%
11.35%
Gross Profit Margin
18.64%
17.91%
19.83%
17.73%
20.34%
27.37%
18.93%
PAT Margin
5.53%
5.02%
5.6%
4.48%
7.8%
24.01%
10.62%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 20.51% vs 22.57% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 35.09% vs 11.76% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 25.06% vs 7.75% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 50.00% vs 100.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Viemed Healthcare, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
270.28
1,660.41
-1,390.13
-83.72%
Other Operating Income
0.00
0.00
0.00
Total Operating income
270.28
1,660.41
-1,390.13
-83.72%
Raw Material Cost
116.31
1,460.82
-1,344.51
-92.04%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
9.13
1,302.55
-1,293.42
-99.30%
Power Cost
0
0
0.00
Manufacturing Expenses
1.18
19.23
-18.05
-93.86%
Selling and Distribution Expenses
129.37
61.22
68.15
111.32%
Other Expenses
-0.73
-132.18
131.45
99.45%
Total Expenditure (Excl Depreciation)
248.70
1,522.04
-1,273.34
-83.66%
Operating Profit (PBDIT) excl Other Income
21.58
138.37
-116.79
-84.40%
Other Income
2.24
18.32
-16.08
-87.77%
Operating Profit (PBDIT)
52.69
193.93
-141.24
-72.83%
Interest
1.18
19.23
-18.05
-93.86%
Exceptional Items
-1.12
-9.21
8.09
87.84%
Gross Profit (PBDT)
153.97
199.59
-45.62
-22.86%
Depreciation
28.61
37.25
-8.64
-23.19%
Profit Before Tax
21.77
128.25
-106.48
-83.03%
Tax
6.39
33.45
-27.06
-80.90%
Provisions and contingencies
0
0
0.00
Profit After Tax
14.93
96.66
-81.73
-84.55%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
14.93
96.66
-81.73
-84.55%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.44
0.00
0.44
Other related items
0.00
0.00
0.00
Consolidated Net Profit
15.38
96.66
-81.28
-84.09%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
141.54
373.37
-231.83
-62.09%
Earnings per share (EPS)
0.37
1.11
-0.74
-66.67%
Diluted Earnings per share
0.37
1.11
-0.74
-66.67%
Operating Profit Margin (Excl OI)
8.08%
8.33%
0.00
-0.25%
Gross Profit Margin
18.64%
9.97%
0.00
8.67%
PAT Margin
5.53%
5.82%
0.00
-0.29%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 27.03 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 20.51% vs 22.57% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 1.54 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 35.09% vs 11.76% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.04 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 25.06% vs 7.75% in Dec 2024
Annual - Interest
Interest 0.12 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 50.00% vs 100.00% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.08%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






